Gallium Maltolate: Innovative Iron-Mimetic Therapy for Cancer and Inflammatory Diseases
Discover the therapeutic potential of Gallium Maltolate, a revolutionary compound targeting cancer and inflammatory conditions.
Get a Quote & SampleProduct Core Value
Gallium Maltolate
Gallium Maltolate (GaM) is a novel orally administered therapeutic agent designed to mimic iron within the body. This unique characteristic allows it to effectively target and inhibit the proliferation of cancer cells and modulate inflammatory processes. GaM offers a significantly improved safety profile and greater convenience compared to existing gallium compounds, making it a leading candidate in the development of new treatments.
- Exploring the oral gallium maltolate mechanism of action reveals its ability to disrupt cancer cell iron metabolism, leading to apoptosis and halting tumor growth.
- Extensive gallium maltolate clinical trials have demonstrated its promising safety and efficacy across a range of malignancies, including glioblastoma and lymphomas.
- The gallium maltolate expanded access program provides a crucial pathway for patients with relapsed or refractory glioblastoma who have exhausted other treatment options.
- Understanding the gallium maltolate safety and efficacy data is vital for its application in precision medicine, particularly for patients identified via gallium-67 scans.
Advantages of Gallium Maltolate
Enhanced Bioavailability and Safety
Gallium maltolate boasts superior oral bioavailability, allowing for convenient daily dosing. Its low toxicity profile, as evidenced in numerous clinical trials, significantly reduces the risk of adverse effects commonly associated with cancer therapies.
Targeted Cancer Therapy
Acting as an iron mimetic, gallium maltolate is selectively taken up by rapidly proliferating cancer cells. Once inside, it interferes with essential cellular processes like DNA synthesis, ultimately leading to cell death. This targeted approach minimizes harm to healthy tissues.
Broad Therapeutic Potential
Beyond cancer, gallium maltolate has shown significant promise in treating various inflammatory and infectious diseases. Its ability to modulate immune responses and combat certain bacterial biofilms opens avenues for broader therapeutic applications.
Key Applications
Cancer Treatment
Gallium maltolate is being investigated as a potent agent for various cancers, including glioblastoma, liver cancer, lymphoma, and more, by disrupting tumor iron metabolism.
Inflammatory Disease Management
Research indicates that gallium maltolate possesses anti-inflammatory properties, making it a candidate for treating conditions driven by chronic inflammation.
Infectious Disease Control
The compound has demonstrated activity against biofilms, particularly those caused by Pseudomonas aeruginosa, suggesting a role in managing persistent infections.
Pediatric Oncology
The FDA has granted orphan drug designation for gallium maltolate in pediatric glioblastoma, highlighting its potential in treating rare childhood cancers.